BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2008
View Archived Issues
Nur77-derived peptide acts as converter of Bcl-2 receptor inducing apoptosis of cancer cells
Read More
Vical receives milestone payment from Merck & Co. for cancer vaccine candidate trial
Read More
Less gastrointestinal mucosal damage seen with aspirin-omeprazole compared to aspirin alone
Read More
Varespladib shows antiatherosclerotic potential in PLASMA-II trial
Read More
Trial suggests metformin chewing gum is bioequivalent to tablets
Read More
MonoSol Rx and Strativa complete bioequivalence studies for ondansetron thin film NDA
Read More
Inhibition of nigrostriatal-thalamic pathway by Trap-101 beneficial in model of PD
Read More
Neuroprotective effects and improved motor performance with metal-chelating agent in PD
Read More
Gene therapy can restore arylsulfatase A expression, possibly treat metachromatic leukodystrophy
Read More
Adeona and NNRI sign research collaboration for animal studies of Flupirtine in RP
Read More
INI treats first patient in phase I/II clinical trial of CellMed's CellBeads for stroke
Read More
Kringle initiates phase II clinical trial in Norway of ChronSeal for venous leg ulcers
Read More
OncoGenex reports positive results from phase II clinical trial of OGX-011 in prostate cancer
Read More
FDA accepts for filing Advanced Life Sciences' NDA for cethromycin in CAP
Read More
Cell Genesys and Takeda suspend development of GVAX, terminate collaboration
Read More
Pozen reports positive top-line phase III results for PN-400
Read More
New glucokinase activators disclosed in recent Takeda and Dainippon Sumitomo Pharma patents
Read More
Yakult initiates clinical study of Campto for pancreatic cancer
Read More
Novel anti-HCV agents patented by Schering-Plough
Read More
Recent Boehringer Ingelheim and GSK patents disclose new therapeutic agents for obesity
Read More
Alkermes initiates phase I ALKS-33 trial in healthy volunteers
Read More
Cerus receives expanded label claim for Intercept Blood System
Read More
MedImmune advances asthma program with phase II MEDI-563 trial
Read More
Oncoscience withdraws Theraloc (nimotuzumab) marketing authorization application
Read More
VentiRx commences phase I VTX-2337 trial in cancer
Read More